Small fiber neuropathy in Parkinson's disease: A clinical, pathological and corneal confocal microscopy study

Lewis Kass-Iliyya, Saad Javed, David Gosal, Christopher Kobylecki, Andrew Marshall, Ioannis N Petropoulos, Georgios Ponirakis, Mitra Tavakoli, Maryam Ferdousi, Kallol Ray Chaudhuri, Maria Jeziorska, Rayaz A Malik, Monty A Silverdale, Lewis Kass-Iliyya, Saad Javed, David Gosal, Christopher Kobylecki, Andrew Marshall, Ioannis N Petropoulos, Georgios Ponirakis, Mitra Tavakoli, Maryam Ferdousi, Kallol Ray Chaudhuri, Maria Jeziorska, Rayaz A Malik, Monty A Silverdale

Abstract

Autonomic and somatic denervation is well established in Parkinson's disease (PD).

Objectives: (1) To determine whether corneal confocal microscopy (CCM) can non-invasively demonstrate small nerve fiber damage in PD. (2) To identify relationships between corneal nerve parameters, intraepidermal nerve fiber density (IENFD) and clinical features of PD.

Methods: Twenty-six PD patients and 26 controls underwent CCM of both eyes. 24/26 PD patients and 10/26 controls underwent skin biopsies from the dorsa of both feet. PD patients underwent assessment of parasympathetic function [deep breathing heart rate variability (DB-HRV)], autonomic symptoms [scale for outcomes in Parkinson's disease - autonomic symptoms (SCOPA-AUT)], motor symptoms [UPDRS-III "ON"] and cumulative Levodopa dose.

Results: PD patients had significantly reduced corneal nerve fiber density (CNFD) with increased corneal nerve branch density (CNBD) and corneal nerve fiber length (CNFL) compared to controls. CNBD and CNFL but not CNFD correlated inversely with UPDRS-III and SCOPA-AUT. All CCM parameters correlated strongly with DB-HRV. There was no correlation between CCM parameters and disease duration, cumulative Levodopa dose or pain. IENFD was significantly reduced in PD compared to controls and correlated with CNFD and UPDRS-III. However, unlike CCM measures, IENFD correlated with disease duration and cumulative Levodopa dose but not with autonomic dysfunction.

Conclusion: CCM identifies corneal nerve fiber pathology, which correlates with autonomic symptoms, parasympathetic deficits and motor scores in patients with PD. IENFD is also reduced and correlates with CNFD and motor symptoms but not parasympathetic deficits, indicating it detects different aspects of peripheral nerve pathology in PD.

Keywords: Confocal microscopy; Cornea; Intraepidermal nerve fiber density; Parkinson's disease; Small fiber neuropathy.

Copyright © 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.

Figures

Fig. 1
Fig. 1
Representative examples of 50 μm sections from skin biopsies immunostained for PGP9.5. Healthy control (A) shows numerous long branching intraepidermal nerve fibers (red arrows) reaching upper layers of epidermis and well developed sub-epidermal nerve plexus (green arrows). Biopsy from a patient with Parkinson's disease (B) showing scant, faintly staining intraepidermal nerve fibers (red arrows), some branches with axonal swellings (red star) and a biopsy from another patient with Parkinson's disease (C) showing an area of epidermis with only one short intraepidermal nerve fiber and signs of degeneration in the sub-epidermal nerve plexus (red stars). Note short nerve fibers, barely crossing epidermal basement membrane (B, C, blue arrows). A–C at the same magnification, scale bar = 100 μm. Corneal confocal image of a healthy control (D) compared to a patient with Parkinson's disease (E) showing a reduction in overall corneal nerve fiber density and increased corneal nerve branch density. Quantification of corneal nerve fiber density, branch density and fiber length is calculated using a semi-automated process. Main fibers are highlighted in red, branches are highlighted in blue and branch origins are represented by the green dots (F&G). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Fig. 2
Fig. 2
Mean ± SEM of corneal nerve fiber density (CNFD) (A), intraepidermal nerve fiber density (IENFD) (B), corneal nerve fiber branch density (CNBD) (C) and fiber length (CNFL) (D) in Parkinson's disease (PD) compared to controls with significance level and effect size.

References

    1. Dabby R., Djaldetti R., Shahmurov M., Treves T.A., Gabai B., Melamed E. Skin biopsy for assessment of autonomic denervation in Parkinson's disease. J. Neural Transm. 2006;113:1169–1176.
    1. Donadio V., Incensi A., Leta V., Giannoccaro M.P., Scaglione C., Martinelli P. Skin nerve alpha-synuclein deposits: a biomarker for idiopathic Parkinson disease. Neurology. 2014;82:1362–1369.
    1. Fujishiro H., Frigerio R., Burnett M., Klos K.J., Josephs K.A., Delledonne A. Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson's disease. Mov. Disord. 2008;23:1085–1092.
    1. Lebouvier T., Neunlist M., Bruley des Varannes S., Coron E., Drouard A., N'Guyen J.M. Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms. PLoS One. 2010;5:e12728.
    1. Wang N., Gibbons C.H., Lafo J., Freeman R. alpha-Synuclein in cutaneous autonomic nerves. Neurology. 2013;81:1604–1610.
    1. Ceravolo R., Cossu G., Bandettini di Poggio M., Santoro L., Barone P., Zibetti M. Neuropathy and levodopa in Parkinson's disease: evidence from a multicenter study. Mov. Disord. 2013;28:1391–1397.
    1. Doppler K., Ebert S., Uceyler N., Trenkwalder C., Ebentheuer J., Volkmann J. Cutaneous neuropathy in Parkinson's disease: a window into brain pathology. Acta Neuropathol. 2014;128:99–109.
    1. Nolano M., Provitera V., Estraneo A., Selim M.M., Caporaso G., Stancanelli A. Sensory deficit in Parkinson's disease: evidence of a cutaneous denervation. Brain. 2008;131:1903–1911.
    1. Rajabally Y.A., Martey J. Levodopa, vitamins, ageing and the neuropathy of Parkinson's disease. J. Neurol. 2013;260:2844–2848.
    1. Toth C., Brown M.S., Furtado S., Suchowersky O., Zochodne D. Neuropathy as a potential complication of levodopa use in Parkinson's disease. Mov. Disord. 2008;23:1850–1859.
    1. Nolano M., Provitera V., Lanzillo B., Santoro L. Neuropathy in idiopathic Parkinson disease: an iatrogenic problem? Ann. Neurol. 2011;69:427–428.
    2. author reply 8–9.
    1. Muller L.J., Marfurt C.F., Kruse F., Tervo T.M. Corneal nerves: structure, contents and function. Exp. Eye Res. 2003;76:521–542.
    1. Quattrini C., Tavakoli M., Jeziorska M., Kallinikos P., Tesfaye S., Finnigan J. Surrogate markers of small fiber damage in human diabetic neuropathy. Diabetes. 2007;56:2148–2154.
    1. Tavakoli M., Begum P., McLaughlin J., Malik R.A. Corneal confocal microscopy for the diagnosis of diabetic autonomic neuropathy. Muscle Nerve. 2015;52:363–370.
    1. Asghar O., Petropoulos I.N., Alam U., Jones W., Jeziorska M., Marshall A. Corneal confocal microscopy detects neuropathy in subjects with impaired glucose tolerance. Diabetes Care. 2014;37:2643–2646.
    1. Ziegler D., Papanas N., Zhivov A., Allgeier S., Winter K., Ziegler I. Early detection of nerve fiber loss by corneal confocal microscopy and skin biopsy in recently diagnosed type 2 diabetes. Diabetes. 2014;63:2454–2463.
    1. Tavakoli M., Mitu-Pretorian M., Petropoulos I.N., Fadavi H., Asghar O., Alam U. Corneal confocal microscopy detects early nerve regeneration in diabetic neuropathy after simultaneous pancreas and kidney transplantation. Diabetes. 2013;62:254–260.
    1. Tavakoli M., Marshall A., Banka S., Petropoulos I.N., Fadavi H., Kingston H. Corneal confocal microscopy detects small-fiber neuropathy in Charcot–Marie–Tooth disease type 1A patients. Muscle Nerve. 2012;46:698–704.
    1. Tavakoli M., Marshall A., Pitceathly R., Fadavi H., Gow D., Roberts M.E. Corneal confocal microscopy: a novel means to detect nerve fibre damage in idiopathic small fibre neuropathy. Exp. Neurol. 2010;223:245–250.
    1. Tavakoli M., Marshall A., Thompson L., Kenny M., Waldek S., Efron N. Corneal confocal microscopy: a novel noninvasive means to diagnose neuropathy in patients with Fabry disease. Muscle Nerve. 2009;40:976–984.
    1. Reddy V.C., Patel S.V., Hodge D.O., Leavitt J.A. Corneal sensitivity, blink rate, and corneal nerve density in progressive supranuclear palsy and Parkinson disease. Cornea. 2013;32:631–635.
    1. Chaudhuri K.R., Martinez-Martin P., Brown R.G., Sethi K., Stocchi F., Odin P. The metric properties of a novel non-motor symptoms scale for Parkinson's disease: results from an international pilot study. Mov. Disord. 2007;22:1901–1911.
    1. Chaudhuri K.R., Rizos A., Trenkwalder C., Rascol O., Pal S., Martino D. King's Parkinson's disease pain scale, the first scale for pain in PD: an international validation. Mov. Disord. 2015;30:1623–1631.
    1. Visser M., Marinus J., Stiggelbout A.M., Van Hilten J.J. Assessment of autonomic dysfunction in Parkinson's disease: the SCOPA-AUT. Mov. Disord. 2004;19:1306–1312.
    1. Young M.J., Boulton A.J., MacLeod A.F., Williams D.R., Sonksen P.H. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 1993;36:150–154.
    1. Lauria G., Hsieh S.T., Johansson O., Kennedy W.R., Leger J.M., Mellgren S.I. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur. J. Neurol. 2010;17:903–912. e44-9.
    1. Schneider C., Bucher F., Cursiefen C., Fink G.R., Heindl L.M., Lehmann H.C. Corneal confocal microscopy detects small fiber damage in chronic inflammatory demyelinating polyneuropathy (CIDP) J. Peripher Nerv. Syst. 2014;19:322–327.
    1. Azmi S., Ferdousi M., Petropoulos I.N., Ponirakis G., Fadavi H., Tavakoli M. Corneal confocal microscopy shows an improvement in small-fiber neuropathy in subjects with type 1 diabetes on continuous subcutaneous insulin infusion compared with multiple daily injection. Diabetes Care. 2015;38:e3–4.
    1. Petropoulos I.N., Alam U., Fadavi H., Asghar O., Green P., Ponirakis G. Corneal nerve loss detected with corneal confocal microscopy is symmetrical and related to the severity of diabetic polyneuropathy. Diabetes Care. 2013;36:3646–3651.
    1. Beiske A.G., Loge J.H., Ronningen A., Svensson E. Pain in Parkinson's disease: prevalence and characteristics. Pain. 2009;141:173–177.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir